Humacyte, Inc.(NASDAQ:HUMA) 
Humacyte, Inc., a clinical-stage biotechnology platform company, develops and manufactures off-the-shelf bioengineered human tissues. The company develops and manufactures acellular tissues to address life- and limb-threatening vascular conditions for complex organ disease. Its Human Acellular Vesse...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.40
H 1.42
L 1.30
C 1.35
V 3,778,915
10EMA 1.35
20EMA 1.35
60EMA 1.35
120EMA 1.35
250EMA 1.35